List of articles with "Atopic Dermatitis"

SkinLink: Enhanced Dermatology

SkinLink: Enhanced Dermatology

USA San Francisco Atopic Dermatitis ixlayer SkinLink
Promising Phase II Results

Promising Phase II Results

China Hangzhou Atopic Dermatitis Lynk Pharmaceuticals LNK01004
SIM0278 Phase II Trials

SIM0278 Phase II Trials

China Hangzhou Atopic Dermatitis Simcere SIM0278
IL-2 Mutant Protein SIM0278

IL-2 Mutant Protein SIM0278

China Hangzhou Atopic Dermatitis Simcere SIM0278
SIM0278 Phase II Trials

SIM0278 Phase II Trials

China Hangzhou Atopic Dermatitis Simcere SIM0278
ENS-002 Shows Promise

ENS-002 Shows Promise

USA Cambridge Atopic Dermatitis Concerto Biosciences ENS-002
Alphyn's New Patent

Alphyn's New Patent

USA Annapolis Atopic Dermatitis Zabalafin Hydrogel Alphyn Biologics
Lilly's EBGLYSS Update

Lilly's EBGLYSS Update

United States Indianapolis Atopic Dermatitis EBGLYSS lebrikizumab
Nevisense in Dermatitis

Nevisense in Dermatitis

Sweden Stockholm Atopic Dermatitis Nevisense SciBase
Bambusa's BBT001 Trial

Bambusa's BBT001 Trial

USA Boston Atopic Dermatitis Bambusa Therapeutics BBT001
TRIV-509 Phase 2 Trial

TRIV-509 Phase 2 Trial

USA Atopic Dermatitis Watertown Triveni Bio TRIV-509
Atopic Dermatitis and Mental Health

Atopic Dermatitis and Mental Health

Paris France mental health Atopic Dermatitis EADV Congress 2025
CAGE Bio Phase 2b

CAGE Bio Phase 2b

United States Atopic Dermatitis San Carlos CAGE Bio CGB-500
Rocatinlimab at EADV 2025

Rocatinlimab at EADV 2025

Japan Tokyo Atopic Dermatitis Kyowa Kirin Rocatinlimab
Zabalafin Hydrogel Breakthrough

Zabalafin Hydrogel Breakthrough

United States Annapolis Atopic Dermatitis Zabalafin Hydrogel Alphyn Biologics
Alphyn CLEAR-AD1 Study

Alphyn CLEAR-AD1 Study

USA Annapolis Atopic Dermatitis Zabalafin Hydrogel Alphyn Biologics
Alphyn's CLEAR-AD1 Trials

Alphyn's CLEAR-AD1 Trials

Annapolis Atopic Dermatitis Zabalafin Hydrogel Alphyn Biologics
Addressing Atopic Dermatitis

Addressing Atopic Dermatitis

USA Boston Atopic Dermatitis Galderma NEMLUVIO
Alphyn's Atopic Dermatitis Trial

Alphyn's Atopic Dermatitis Trial

United States Annapolis Atopic Dermatitis Zabalafin Hydrogel Alphyn Biologics
EVO301 Phase 2 Trial Launch

EVO301 Phase 2 Trial Launch

United States Palo Alto Atopic Dermatitis Evommune EVO301
Zabalafin Hydrogel Unveiled

Zabalafin Hydrogel Unveiled

United States Orlando Atopic Dermatitis Zabalafin Hydrogel Alphyn Biologics
EBGLYSS® Breakthrough

EBGLYSS® Breakthrough

United States Indianapolis Atopic Dermatitis Eli Lilly EBGLYSS
Bambusa Trials Innovation

Bambusa Trials Innovation

USA Boston Atopic Dermatitis Bambusa Therapeutics BBT001
Wearable Tech for Nighttime Itch

Wearable Tech for Nighttime Itch

USA Chicago Atopic Dermatitis Sibel Health ADAM Sensor
REZOLVE-AD Study Update

REZOLVE-AD Study Update

United States San Francisco Atopic Dermatitis Nektar Therapeutics Rezpegaldesleukin
TDM-180935 Trial Success

TDM-180935 Trial Success

China Chengdu Atopic Dermatitis Technoderma TDM-180935
Alphyn's New Patent

Alphyn's New Patent

United States Annapolis Atopic Dermatitis Zabalafin Hydrogel Alphyn Biologics
Minghui Phase Ⅲ Results

Minghui Phase Ⅲ Results

Shanghai Minghui Pharmaceutical MH004 Atopic Dermatitis

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.